Monthly Update: Biologicals & Immunologicals: Progress with humanised antibodies - An update

This publication has 19 references indexed in Scilit:

• THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITIS
  Rheumatology, 1995
• The Vector Void in Gene Therapy
  Nature Biotechnology, 1995
• Bispecific HER2 × CD3 Antibodies Enhance T-Cell Cytotoxicity in Vitro and Localize to HER2-Overexpressing Xenografts in Nude Mice
  Clinical Immunology and Immunopathology, 1995
• Section Review: Humanised monoclonal antibodies for therapeutic applications
  Expert Opinion on Investigational Drugs, 1994
• Humanization of murine monoclonal antibodies through variable domain resurfacing.
  Proceedings of the National Academy of Sciences, 1994
• Clinical Results with Humanized and Human Monoclonal Antibodies
  Published by Springer Nature ,1994
• High-level production of recombinant immunoglobulins in mammalian cells
  Current Opinion in Biotechnology, 1993
• High Level Escherichia coli Expression and Production of a Bivalent Humanized Antibody Fragment
  Nature Biotechnology, 1992
• Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
  The Journal of Experimental Medicine, 1992
• Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients
  The Journal of Infectious Diseases, 1991